Methods and Compositions for the Treatment and Diagnosis of Bladder Cancer
AssigneeOncocyte Corporation
InventorsKaren Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd
Life of this patent
Estimating the term…
Loading patent…
AssigneeOncocyte Corporation
InventorsKaren Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd
Estimating the term…
Embodiments of the disclosure are directed to methods of diagnosis, prognosis and treatment of cancer. The methods are particularly suited for bladder cancer. The methods include targeting a marker that is expressed at abnormal levels in bladder cancer tissue in comparison to normal somatic tissue. Also disclosed are methods of treating cancer comprising administering a composition including a therapeutic that affects the expression or function of a target marker.
1-13. (canceled)
A kit comprising a plurality of agents that bind to a plurality of markers chosen from COL10A1, FCRLB, AIM2, KRT6A, and MMP11.
Dependencies are inferred from the claim text.